07:34 AM EDT, 04/07/2025 (MT Newswires) -- ADMA Biologics ( ADMA ) said Monday it doesn't expect the latest US tariffs on foreign goods and services to have any impact on its supply chain or production operations.

The company's manufacturing operations, end-market sales, and customer engagements are all conducted exclusively within the US, Chief Executive Adam Grossman said.